Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

19 Sept 2003

Abstract excerpt

The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to aggressive prostate cancer. Here we investigate the functional role of EZH2 in cancer cell invasion and breast cancer progression. EZH2 transcript and protein were consistently elevated in invasive breast carcinoma compared with normal breast epithelia. Tissue microarray analysis, which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related gene regulation
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14500907
DOI: 10.1073/pnas.1933744100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsPMID 14500907Read ↗

Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.Semantic proximity Read ↗

EZH2-associated tumor malignancy: A prominent target for cancer treatment.Semantic proximity Read ↗

Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.Semantic proximity Read ↗

The polycomb group protein EZH2 is involved in progression of prostate cancer.Semantic proximity Read ↗

A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer OutcomeSemantic proximity Read ↗

Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.Semantic proximity Read ↗

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.Semantic proximity Read ↗

EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressivenessSemantic proximity Read ↗

EZH2 expands breast stem cells through activation of NOTCH1 signalingSemantic proximity Read ↗

EZH2 represses mesenchymal genes and upholds the epithelial state of breast carcinoma cellsSemantic proximity Read ↗

Targeting EZH2 in cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.